GW-6604

N1C=C(C(=N1)C2=NC=CC=C2)C3=CC(=NC=C3)C4=CC=CC=C4

InChIKey=BDCBRQYHYNUWAM-UHFFFAOYSA-N

InChI=1S/C19H14N4/c1-2-6-14(7-3-1)18-12-15(9-11-21-18)16-13-22-23-19(16)17-8-4-5-10-20-17/h1-13H,(H,22,23)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Inhibition of ALK5 as a new approach to treat liver fibrotic diseases.	2006-03	16628263
Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.	2005-05	15723089

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:44:25 GMT 2025` Edited by `admin` on `Mon Mar 31 21:44:25 GMT 2025`
Record UNII	273G6SN31H
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

2-PHENYL-4-(3-(PYRIDIN-2-YL)-1H-PYRAZOL-4-YL)PYRIDINE

Preferred Name

English

GW-6604

Common Name

English

PYRIDINE, 2-PHENYL-4-(3-(2-PYRIDINYL)-1H-PYRAZOL-4-YL)-

Systematic Name

English

Code System Code Type Description

CAS

452342-37-9

Created by admin on Mon Mar 31 21:44:25 GMT 2025 , Edited by admin on Mon Mar 31 21:44:25 GMT 2025

PRIMARY

PUBCHEM

9861063

Created by admin on Mon Mar 31 21:44:25 GMT 2025 , Edited by admin on Mon Mar 31 21:44:25 GMT 2025

PRIMARY

FDA UNII

273G6SN31H

Created by admin on Mon Mar 31 21:44:25 GMT 2025 , Edited by admin on Mon Mar 31 21:44:25 GMT 2025

PRIMARY

Related Record Type Details


					273G6SN31H

GW-6604

ACTIVE MOIETY